The following is a reconciliation for the calculation of basic and diluted loss per share for the years ended December 31, 2025 and 2024:


	Year Ended December 31,

($ in thousands, except per share amounts)		2025		2024
Numerator:
Net loss		$	(140,044)	$	(60,489)
Less: Net loss (income) attributable to non-controlling interests, net of tax		(4,636)		13,949
Net loss attributable to Cresco Labs Inc.		$	(135,408)	$	(74,438)

Denominator:
Weighted-average basic and diluted shares outstanding		355,007,044		345,474,155






Loss per Share:
Basic and diluted loss per share		$	(0.38)	$	(0.22)

For the years ended December 31, 2025 and 2024, weighted-average potentially dilutive shares were not included in the computation of diluted loss per common share due to the net loss during the periods presented because the shares would have had an anti-dilutive effect. Weighted-average potentially dilutive shares for the years ended December 31, 2025 and 2024, consisted of the following:


	Year Ended December 31,

(shares in thousands)		2025	2024
Redeemable Units		88,550	92,057
Stock options		24,781	24,153
RSUs		14,521	8,927
Total potentially dilutive shares		127,852	125,137